首页 > 最新文献

BMC Urology最新文献

英文 中文
Intraperitoneal laparoscopic technique in trendelenburg position: an effective surgical method for pyelolithotomy, pyeloplasty, and heminephrectomy in patients with horseshoe kidneys. 腹腔内腹腔镜技术:马蹄肾患者肾盂切开术、肾盂成形术和半肾切除术的有效手术方法。
IF 1.7 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-28 DOI: 10.1186/s12894-024-01631-4
Ming Xiong, Zhaohui Chen, Xiaoming Wang, Huiling Jiang, Zhicheng Luo, Guancai Liang, Teng Hou

Purpose: To evaluate the safety and feasibility of intraperitoneal laparoscopic surgery in Trendelenburg position (ILSTP) for pyelolithotomy, pyeloplasty, and heminephrectomy in patients with horseshoe kidneys (HSKs).

Methods: Between March 2021 and March 2024, three patients with HSKs underwent ILSSP. Of these three patients, two with pelvi-ureteric junction obstruction with recurrent kidney stones underwent pyelolithotomy and pyeloplasty, one with symptomatic nonfunctioning left moiety of a HSK was managed with heminephrectomy.

Results: Mean operating time was 114 ± 64.8 (44-172) min, and estimated blood loss was 63.3 ± 51.3 (20-120) ml. The mean hospital stay was 3.3 ± 1.5 (2-5) days. There were no major intra- or post-operative complications.

Conclusions: ILSTP is a feasible and effective technique for performing pyelolithotomy, pyeloplasty, and heminephrectomy in patients with HSKs.

目的:评估马蹄肾(HSKs)患者在 Trendelenburg 体位(ILSTP)下接受腹腔镜手术进行肾盂切开术、肾盂成形术和半肾切除术的安全性和可行性:在 2021 年 3 月至 2024 年 3 月期间,三名 HSK 患者接受了 ILSSP。在这三名患者中,两名患有肾盂输尿管交界处梗阻并伴有复发性肾结石的患者接受了肾盂切开术和肾盂成形术,一名患有HSK左侧无症状无功能的患者接受了半肾切除术:平均手术时间为 114 ± 64.8 (44-172) 分钟,估计失血量为 63.3 ± 51.3 (20-120) 毫升。平均住院时间为 3.3 ± 1.5 (2-5) 天。术中和术后均无重大并发症:ILSTP是为HSK患者实施肾盂切开术、肾盂成形术和半肾切除术的一种可行且有效的技术。
{"title":"Intraperitoneal laparoscopic technique in trendelenburg position: an effective surgical method for pyelolithotomy, pyeloplasty, and heminephrectomy in patients with horseshoe kidneys.","authors":"Ming Xiong, Zhaohui Chen, Xiaoming Wang, Huiling Jiang, Zhicheng Luo, Guancai Liang, Teng Hou","doi":"10.1186/s12894-024-01631-4","DOIUrl":"10.1186/s12894-024-01631-4","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the safety and feasibility of intraperitoneal laparoscopic surgery in Trendelenburg position (ILSTP) for pyelolithotomy, pyeloplasty, and heminephrectomy in patients with horseshoe kidneys (HSKs).</p><p><strong>Methods: </strong>Between March 2021 and March 2024, three patients with HSKs underwent ILSSP. Of these three patients, two with pelvi-ureteric junction obstruction with recurrent kidney stones underwent pyelolithotomy and pyeloplasty, one with symptomatic nonfunctioning left moiety of a HSK was managed with heminephrectomy.</p><p><strong>Results: </strong>Mean operating time was 114 ± 64.8 (44-172) min, and estimated blood loss was 63.3 ± 51.3 (20-120) ml. The mean hospital stay was 3.3 ± 1.5 (2-5) days. There were no major intra- or post-operative complications.</p><p><strong>Conclusions: </strong>ILSTP is a feasible and effective technique for performing pyelolithotomy, pyeloplasty, and heminephrectomy in patients with HSKs.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"236"},"PeriodicalIF":1.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transvaginal posterior levatorplasty and perineoplasty for female primary stress urinary incontinence: 12-month follow-up and technical presentation. 经阴道后悬雍垂成形术和会阴成形术治疗女性原发性压力性尿失禁:12 个月随访和技术展示。
IF 1.7 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-26 DOI: 10.1186/s12894-024-01604-7
Yansheng Xu, Lan Wei, Meichen Liu, Zhuomin Jia, Yilin Li, Fengyong Li

Objective: To investigate the feasibility of transvaginal posterior levatorplasty combined with perineoplasty (TPLP) for women with primary stress urinary incontinence and demonstrate the surgical technique with step-by-step procedures.

Methods: A prospective, non-randomised study was conducted using technique of TPLP to treat female primary SUI from January 2019 to December 2021. Patient follow-up was performed at 3 and 12 months posteroperatively. A series of validated questionnaires were used to evaluate the improvement of symptom severity, sexual function and quality of life. In addition, 4-D ultrasonography was used to measure the anatomic changes of pelvic structures.

Results: A total of 47 patients were enrolled in this study with a mean age of 43.6 years. Mean operative time was 78.7 min. Median estimated intraoperative blood loss was 80.2 ml. Objective cure and subjective cure rates were 87.2% and 91.5%, respectively. Compared with baseline, scores of quality of life, symptom severity and sexual function improved after surgery. Meanwhile, mobility of the urethra and bladder neck and areas of levator hiatus were decreased after surgery. Mild coitus pain was reported in 15.4% (6/39) patients at the initial several times of intercourse after resuming sexual activity.

Conclusions: This study shows that transvaginal posterior levatorplasty combined with perineoplasty appears to be an effective surgical method for selected women with primary stress urinary incontinence.

目的研究经阴道后悬雍垂成形术联合会阴成形术(TPLP)治疗女性原发性压力性尿失禁的可行性,并通过逐步操作演示手术技巧:方法:2019 年 1 月至 2021 年 12 月期间进行了一项前瞻性非随机研究,采用 TPLP 技术治疗女性原发性 SUI。术后 3 个月和 12 个月对患者进行随访。研究采用了一系列经过验证的问卷来评估症状严重程度、性功能和生活质量的改善情况。此外,还使用了四维超声波来测量骨盆结构的解剖变化:结果:共有 47 名患者参与了这项研究,平均年龄为 43.6 岁。平均手术时间为 78.7 分钟。术中估计失血量中位数为 80.2 毫升。客观治愈率和主观治愈率分别为 87.2% 和 91.5%。与基线相比,术后生活质量、症状严重程度和性功能评分均有所改善。同时,术后尿道和膀胱颈的活动度以及外翻裂孔的面积都有所减少。15.4%的患者(6/39)在恢复性生活后的最初几次性交中出现轻度同房疼痛:这项研究表明,经阴道后方提上睑肌成形术联合会阴成形术似乎是一种有效的手术方法,适用于部分患有原发性压力性尿失禁的女性。
{"title":"Transvaginal posterior levatorplasty and perineoplasty for female primary stress urinary incontinence: 12-month follow-up and technical presentation.","authors":"Yansheng Xu, Lan Wei, Meichen Liu, Zhuomin Jia, Yilin Li, Fengyong Li","doi":"10.1186/s12894-024-01604-7","DOIUrl":"10.1186/s12894-024-01604-7","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the feasibility of transvaginal posterior levatorplasty combined with perineoplasty (TPLP) for women with primary stress urinary incontinence and demonstrate the surgical technique with step-by-step procedures.</p><p><strong>Methods: </strong>A prospective, non-randomised study was conducted using technique of TPLP to treat female primary SUI from January 2019 to December 2021. Patient follow-up was performed at 3 and 12 months posteroperatively. A series of validated questionnaires were used to evaluate the improvement of symptom severity, sexual function and quality of life. In addition, 4-D ultrasonography was used to measure the anatomic changes of pelvic structures.</p><p><strong>Results: </strong>A total of 47 patients were enrolled in this study with a mean age of 43.6 years. Mean operative time was 78.7 min. Median estimated intraoperative blood loss was 80.2 ml. Objective cure and subjective cure rates were 87.2% and 91.5%, respectively. Compared with baseline, scores of quality of life, symptom severity and sexual function improved after surgery. Meanwhile, mobility of the urethra and bladder neck and areas of levator hiatus were decreased after surgery. Mild coitus pain was reported in 15.4% (6/39) patients at the initial several times of intercourse after resuming sexual activity.</p><p><strong>Conclusions: </strong>This study shows that transvaginal posterior levatorplasty combined with perineoplasty appears to be an effective surgical method for selected women with primary stress urinary incontinence.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"235"},"PeriodicalIF":1.7,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11515089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and safety of flexible ureteroscopy with intelligent control of renal pelvis pressure without urinary catheter: a retrospective study. 无需导尿管的智能控制肾盂压力的柔性输尿管镜检查的可行性和安全性:一项回顾性研究。
IF 1.7 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-24 DOI: 10.1186/s12894-024-01628-z
Huang Mei, Yang Baihua, Luo Xiaohua, Song Leming, Deng Xiaolin

Background: To explore the feasibility and safety of aflexible ureteroscopy with intelligent control of renal pelvic pressure(FUS-ICP) without a post-operative indwelling urinary catheter .

Methods: In this retrospective study, we assessed patients with upper urinary tract stones who were treated with FUS-ICP at the Ganzhou People's Hospital from February 2022 to December 2023. Patients were divided into the non-urinary catheter (non-UC) and urinary catheter (UC) groups according to whether an indwelling catheter was used after surgery.

Results: In total, 142 patients were included in the study. There was no significant difference in the preoperative general data between the two groups. Patients in the non-UC group performed better than those in the UC group in terms of catheter-related bladder irritation (P = 0.001), the Sedation-Agitation Scale score (P = 0.012), and the numerical rating scale (P = 0.003). The incidences of urinary retention (P = 0.620), urinary tract infection (P = 0.529), and replacement of urethral catheter s (P = 0.438) in the UC group were inferior to those in the non-UC group, but there was no statistical significance.

Conclusions: It is feasible and safe to perform FUS-ICP without a post-procedure indwelling urinary catheter.

背景:探讨智能控制肾盂压力的柔性输尿管镜(FUS-ICP)的可行性和安全性:目的:探讨术后无需留置导尿管的智能控制肾盂压力的柔性输尿管镜(FUS-ICP)的可行性和安全性。 方法:我们对2022年2月至2023年12月在赣州市人民医院接受FUS-ICP治疗的上尿路结石患者进行了回顾性研究:在这项回顾性研究中,我们对2022年2月至2023年12月在赣州市人民医院接受FUS-ICP治疗的上尿路结石患者进行了评估。根据术后是否使用留置导尿管,将患者分为非留置导尿管组(non-urinary catheter,简称UC)和留置导尿管组(urinary catheter,简称UC):共有142名患者参与了研究。两组患者术前的一般数据无明显差异。就导尿管相关的膀胱刺激(P = 0.001)、镇静-镇痛量表评分(P = 0.012)和数字评分量表(P = 0.003)而言,非 UC 组患者的表现优于 UC 组患者。UC 组尿潴留(P = 0.620)、尿路感染(P = 0.529)和尿道导管更换(P = 0.438)的发生率低于非 UC 组,但无统计学意义:结论:在不使用术后留置导尿管的情况下进行 FUS-ICP 是可行且安全的。
{"title":"Feasibility and safety of flexible ureteroscopy with intelligent control of renal pelvis pressure without urinary catheter: a retrospective study.","authors":"Huang Mei, Yang Baihua, Luo Xiaohua, Song Leming, Deng Xiaolin","doi":"10.1186/s12894-024-01628-z","DOIUrl":"10.1186/s12894-024-01628-z","url":null,"abstract":"<p><strong>Background: </strong>To explore the feasibility and safety of aflexible ureteroscopy with intelligent control of renal pelvic pressure(FUS-ICP) without a post-operative indwelling urinary catheter .</p><p><strong>Methods: </strong>In this retrospective study, we assessed patients with upper urinary tract stones who were treated with FUS-ICP at the Ganzhou People's Hospital from February 2022 to December 2023. Patients were divided into the non-urinary catheter (non-UC) and urinary catheter (UC) groups according to whether an indwelling catheter was used after surgery.</p><p><strong>Results: </strong>In total, 142 patients were included in the study. There was no significant difference in the preoperative general data between the two groups. Patients in the non-UC group performed better than those in the UC group in terms of catheter-related bladder irritation (P = 0.001), the Sedation-Agitation Scale score (P = 0.012), and the numerical rating scale (P = 0.003). The incidences of urinary retention (P = 0.620), urinary tract infection (P = 0.529), and replacement of urethral catheter s (P = 0.438) in the UC group were inferior to those in the non-UC group, but there was no statistical significance.</p><p><strong>Conclusions: </strong>It is feasible and safe to perform FUS-ICP without a post-procedure indwelling urinary catheter.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"234"},"PeriodicalIF":1.7,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11515462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison in prostate cancer diagnosis with PSA 4-10 ng/mL: radiomics-based model VS. PI-RADS v2.1. PSA 为 4-10 纳克/毫升时的前列腺癌诊断比较:基于放射组学的模型 VS.PI-RADS v2.1。
IF 1.7 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-23 DOI: 10.1186/s12894-024-01625-2
Chunxing Li, Zhicheng Jin, Chaogang Wei, Guangcheng Dai, Jian Tu, Junkang Shen

Background: To evaluate accuracy of MRI-based radiomics in diagnosing prostate cancer (PCa) in patients with PSA levels between 4 and 10 ng/mL and compare it with the latest Prostate Imaging Reporting and Data System (PI-RADS v2.1) score.

Methods: 221 patients with prostate lesions and PSA levels in 4-10 ng/mL, including 154 and 67 cases in the training and validation groups. Pathological confirmation of all patients was accomplished by the use of MRI-TRUS fusion targeted biopsy or systematic transrectal ultrasound (TRUS) guided biopsy. 851 radiomic features were extracted from each lesion of ADC and T2WI images. The least absolute shrinkage and selection operator (LASSO) regression algorithm and logistic regression were employed to select features and build the ADC and T2WI model. The combined model was obtained based on the ADC and T2WI features. The clinical benefit and diagnostic accuracy of the three radiomics models and PI-RADS v2.1 score were evaluated.

Results: 10 radiomic features were ultimately selected from the ADC images, 13 from the T2WI images and 7 from the combined models. The ADC, T2WI and combined models achieved satisfactory diagnostic accuracy in the training [AUC:0.945 (ADC), 0.939 (T2WI), 0.979 (combined)] and validation groups [AUC: 0.942 (ADC), 0.943 (T2WI), 0.959 (combined)], which was significantly higher than those in PI-RADS v2.1 model (0.825 for training cohort and 0.853 for validation cohort). Compared with the PI-RADS v2.1 score, the three radiomics models generated superior PCa diagnostic performance in both the training (p = 0.002, p = 0.005, p < 0.001) and validation groups (p = 0.045, p = 0.035, p = 0.015).

Conclusion: Radiomics based on ADC and T2WI images can better identify PCa in patients with PSA 4-10 ng/mL, and MRI-based radiomics significantly outperforms the PI-RADS v2.1 score.

Clinical trial number: Not applicable.

背景:方法:221例前列腺病变且PSA水平在4-10纳克/毫升的患者,包括训练组154例和验证组67例。所有患者的病理确认均通过磁共振成像-TRUS融合靶向活检或系统经直肠超声(TRUS)引导活检完成。从每个病灶的 ADC 和 T2WI 图像中提取了 851 个放射学特征。采用最小绝对收缩和选择算子(LASSO)回归算法和逻辑回归来选择特征并建立 ADC 和 T2WI 模型。根据 ADC 和 T2WI 特征得到综合模型。评估了三种放射组学模型和 PI-RADS v2.1 评分的临床效益和诊断准确性:结果:最终从 ADC 图像中选出了 10 个放射组学特征,从 T2WI 图像中选出了 13 个,从组合模型中选出了 7 个。ADC、T2WI 和组合模型在训练组[AUC:0.945(ADC),0.939(T2WI),0.979(组合)]和验证组[AUC:0.942(ADC),0.943(T2WI),0.959(组合)]都达到了令人满意的诊断准确率,明显高于 PI-RADS v2.1 模型(训练组为 0.825,验证组为 0.853)。与 PI-RADS v2.1 评分相比,三种放射组学模型在培训组和验证组中的 PCa 诊断性能都更优越(P = 0.002、P = 0.005、P = 0.005):基于ADC和T2WI图像的放射组学能更好地识别PSA为4-10纳克/毫升的PCa患者,基于MRI的放射组学明显优于PI-RADS v2.1评分:临床试验编号:不适用。
{"title":"Comparison in prostate cancer diagnosis with PSA 4-10 ng/mL: radiomics-based model VS. PI-RADS v2.1.","authors":"Chunxing Li, Zhicheng Jin, Chaogang Wei, Guangcheng Dai, Jian Tu, Junkang Shen","doi":"10.1186/s12894-024-01625-2","DOIUrl":"10.1186/s12894-024-01625-2","url":null,"abstract":"<p><strong>Background: </strong>To evaluate accuracy of MRI-based radiomics in diagnosing prostate cancer (PCa) in patients with PSA levels between 4 and 10 ng/mL and compare it with the latest Prostate Imaging Reporting and Data System (PI-RADS v2.1) score.</p><p><strong>Methods: </strong>221 patients with prostate lesions and PSA levels in 4-10 ng/mL, including 154 and 67 cases in the training and validation groups. Pathological confirmation of all patients was accomplished by the use of MRI-TRUS fusion targeted biopsy or systematic transrectal ultrasound (TRUS) guided biopsy. 851 radiomic features were extracted from each lesion of ADC and T2WI images. The least absolute shrinkage and selection operator (LASSO) regression algorithm and logistic regression were employed to select features and build the ADC and T2WI model. The combined model was obtained based on the ADC and T2WI features. The clinical benefit and diagnostic accuracy of the three radiomics models and PI-RADS v2.1 score were evaluated.</p><p><strong>Results: </strong>10 radiomic features were ultimately selected from the ADC images, 13 from the T2WI images and 7 from the combined models. The ADC, T2WI and combined models achieved satisfactory diagnostic accuracy in the training [AUC:0.945 (ADC), 0.939 (T2WI), 0.979 (combined)] and validation groups [AUC: 0.942 (ADC), 0.943 (T2WI), 0.959 (combined)], which was significantly higher than those in PI-RADS v2.1 model (0.825 for training cohort and 0.853 for validation cohort). Compared with the PI-RADS v2.1 score, the three radiomics models generated superior PCa diagnostic performance in both the training (p = 0.002, p = 0.005, p < 0.001) and validation groups (p = 0.045, p = 0.035, p = 0.015).</p><p><strong>Conclusion: </strong>Radiomics based on ADC and T2WI images can better identify PCa in patients with PSA 4-10 ng/mL, and MRI-based radiomics significantly outperforms the PI-RADS v2.1 score.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"233"},"PeriodicalIF":1.7,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11515792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of efficacy and safety of low-intensity pulsed ultrasound in patients with concurrent erectile dysfunction and chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized controlled study. 评估低强度脉冲超声对同时患有勃起功能障碍和慢性前列腺炎/慢性盆腔疼痛综合征的患者的疗效和安全性:一项前瞻性随机对照研究。
IF 1.7 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-22 DOI: 10.1186/s12894-024-01630-5
Zhongyi Li, Dongjie Li, Xiongbing Zu, Boyu Xiang, Guilin Wang, Zhengyan Tang

Objective: The primary objective of this clinical trial is to investigate the effect of low-intensity pulsed ultrasound (LIPUS) on patients suffering from comorbid erectile dysfunction (ED) and chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS).

Methods: The clinical trial was conducted in the andrology outpatient treatment room of the Department of Urology, Xiangya Hospital, Central South University from August to November 2022 A total of 60 patients who met the research criteria for comorbid ED combined with CP/CPPS were recruited and randomly assigned to three treatment groups. They were treated with LIPUS (Group A), drug therapy(Group B), and LIPUS combined with drug therapy (Group C), respectively. Each group comprised 20 patients. Statistical analysis was performed on the five-item version of International Index of Erectile Function (IIEF-5), Erection Hardness Score (EHS), National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), the nine-item Patient Health Questionnaire (PHQ-9), the seven-item Generalized Anxiety Disorder Scale (GAD-7), and the incidence of adverse events to comprehensively evaluate the efficacy and safety of LIPUS.

Results: The positive response rate of ED and CP/CPPS treatment in Group A is 40%(8/20) and 45%(9/20), while those in Group B is 55%(11/20) and 60%(12/20), and those in Group C is 85%(17/20) and 85%(17/20). A notable increase in IIEF-5 scores was observed across the three groups post-treatment (10.45 ± 2.50 vs. 13.65 ± 3.03, P = 0.008; 11.80 ± 3.21 vs. 16.40 ± 3.20, P = 0.011; 12.90 ± 3.92 vs. 19.40 ± 2.35, P = 0.042) with a concomitant significant decrease in NIH-CPSI scores (16.75 ± 4.53 vs. 14.65 ± 4.51, P = 0.016; 16.35 ± 4.32 vs. 12.20 ± 4.74, P = 0.007; 16.00 ± 4.40 vs. 8.15 ± 4.28, P = 0.021). Notably, the most pronounced changes were seen in the group receiving LIPUS combined with tadalafil and doxazosin. Additionally, all groups exhibited marked improvements in anxiety and depression symptoms post-treatment. No adverse events were observed during treatment.

Conclusion: LIPUS can improve erectile function and CP/CPPS symptoms with good safety, and LIPUS combined with tadalafil and doxazosin is more effective during the treatment. However, its long-term efficacy remains to be seen.

Trial registration: Chinese Clinical Trial Registry; approval number: ChiCTR2200063038 ( https://www.chictr.org.cn/ ) on August 29, 2022.

研究目的本临床试验的主要目的是探讨低强度脉冲超声(LIPUS)对合并勃起功能障碍(ED)和慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)患者的影响:临床试验于2022年8月至11月在中南大学湘雅医院泌尿外科泌尿外科门诊治疗室进行,共招募了60名符合研究标准的合并勃起功能障碍(ED)和慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)的患者,并将他们随机分配到三个治疗组。他们分别接受LIPUS治疗(A组)、药物治疗(B组)和LIPUS联合药物治疗(C组)。每组 20 名患者。对五项国际勃起功能指数(IIEF-5)、勃起硬度评分(EHS)、美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)、九项患者健康问卷(PHQ-9)、七项广泛性焦虑症量表(GAD-7)以及不良反应发生率进行统计分析,以全面评估LIPUS的疗效和安全性:结果:A组对ED和CP/CPPS治疗的阳性反应率分别为40%(8/20)和45%(9/20),B组为55%(11/20)和60%(12/20),C组为85%(17/20)和85%(17/20)。治疗后,三组患者的 IIEF-5 评分均有显著提高(10.45 ± 2.50 vs. 13.65 ± 3.03,P = 0.008;11.80 ± 3.21 vs. 16.40 ± 3.20,P = 0.011;12.90 ± 3.92 vs. 19.40 ± 2.35,P = 0.042)。35, P = 0.042),同时 NIH-CPSI 评分显著下降(16.75 ± 4.53 vs. 14.65 ± 4.51, P = 0.016; 16.35 ± 4.32 vs. 12.20 ± 4.74, P = 0.007; 16.00 ± 4.40 vs. 8.15 ± 4.28, P = 0.021)。值得注意的是,接受 LIPUS 联合他达拉非和多沙唑嗪治疗的组别变化最为明显。此外,所有治疗组在治疗后的焦虑和抑郁症状都有明显改善。治疗期间未发现任何不良反应:结论:LIPUS可改善勃起功能和CP/CPPS症状,且安全性良好,LIPUS联合他达拉非和多沙唑嗪治疗效果更佳。但其长期疗效仍有待观察:试验注册:中国临床试验注册中心;批准号:ChiCTR2200063038:试验注册:中国临床试验注册中心;批准号:ChiCTR2200063038 ( https://www.chictr.org.cn/ ) 2022年8月29日。
{"title":"Evaluation of efficacy and safety of low-intensity pulsed ultrasound in patients with concurrent erectile dysfunction and chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized controlled study.","authors":"Zhongyi Li, Dongjie Li, Xiongbing Zu, Boyu Xiang, Guilin Wang, Zhengyan Tang","doi":"10.1186/s12894-024-01630-5","DOIUrl":"https://doi.org/10.1186/s12894-024-01630-5","url":null,"abstract":"<p><strong>Objective: </strong>The primary objective of this clinical trial is to investigate the effect of low-intensity pulsed ultrasound (LIPUS) on patients suffering from comorbid erectile dysfunction (ED) and chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS).</p><p><strong>Methods: </strong>The clinical trial was conducted in the andrology outpatient treatment room of the Department of Urology, Xiangya Hospital, Central South University from August to November 2022 A total of 60 patients who met the research criteria for comorbid ED combined with CP/CPPS were recruited and randomly assigned to three treatment groups. They were treated with LIPUS (Group A), drug therapy(Group B), and LIPUS combined with drug therapy (Group C), respectively. Each group comprised 20 patients. Statistical analysis was performed on the five-item version of International Index of Erectile Function (IIEF-5), Erection Hardness Score (EHS), National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), the nine-item Patient Health Questionnaire (PHQ-9), the seven-item Generalized Anxiety Disorder Scale (GAD-7), and the incidence of adverse events to comprehensively evaluate the efficacy and safety of LIPUS.</p><p><strong>Results: </strong>The positive response rate of ED and CP/CPPS treatment in Group A is 40%(8/20) and 45%(9/20), while those in Group B is 55%(11/20) and 60%(12/20), and those in Group C is 85%(17/20) and 85%(17/20). A notable increase in IIEF-5 scores was observed across the three groups post-treatment (10.45 ± 2.50 vs. 13.65 ± 3.03, P = 0.008; 11.80 ± 3.21 vs. 16.40 ± 3.20, P = 0.011; 12.90 ± 3.92 vs. 19.40 ± 2.35, P = 0.042) with a concomitant significant decrease in NIH-CPSI scores (16.75 ± 4.53 vs. 14.65 ± 4.51, P = 0.016; 16.35 ± 4.32 vs. 12.20 ± 4.74, P = 0.007; 16.00 ± 4.40 vs. 8.15 ± 4.28, P = 0.021). Notably, the most pronounced changes were seen in the group receiving LIPUS combined with tadalafil and doxazosin. Additionally, all groups exhibited marked improvements in anxiety and depression symptoms post-treatment. No adverse events were observed during treatment.</p><p><strong>Conclusion: </strong>LIPUS can improve erectile function and CP/CPPS symptoms with good safety, and LIPUS combined with tadalafil and doxazosin is more effective during the treatment. However, its long-term efficacy remains to be seen.</p><p><strong>Trial registration: </strong>Chinese Clinical Trial Registry; approval number: ChiCTR2200063038 ( https://www.chictr.org.cn/ ) on August 29, 2022.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"232"},"PeriodicalIF":1.7,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Open versus mini-invasive partial and radical nephrectomy complications: results from the French national health database. 开放式与微创肾部分切除术和根治性肾切除术的并发症:法国国家健康数据库的结果。
IF 1.7 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-21 DOI: 10.1186/s12894-024-01620-7
Guillaume Pascal, Pascal Eschwège, Julia Salleron, Beverley Balkau, Jacques Hubert, Charles Mazeaud

Background: Laparoscopic surgery is associated with a lower morbidity than open surgery. No recent data compared kidney cancer surgery in the French population using the National Health Insurance database (PMSI-MCO).

Aims: We explore and compare the surgical morbidity rates between laparoscopic and open laparotomy for kidney cancer.

Methods: The initial length of stay and complications parameters during the three postoperative months were described for renal cancer in every French center in 2018. We compared Relative Risks (RR [95% CI]) between laparoscopic and open surgery for both radical and partial nephrectomy.

Results: Among 8,162 patients, 3,525 had a radical nephrectomy, 978 open, 2,547 laparoscopic surgeries; 4,637 patients had partial nephrectomies, 1,778 open 2,859 laparoscopic surgeries. For radical surgery, the most common complications were urinary infections (7.8%), acute renal failure (8.9%), sepsis (8.4%), bleeding (9.3%), and postoperative anemia (5.9%); the RR for laparoscopic versus open surgery were respectively 0.68 [0.54;0.86], 0.71 [0.57;0.88], 0.69 [0.55;0.86], 0.83 [0.66;1.03], 0.56 [0.43;0.73]. For partial nephrectomies, the most common complications were urinary infections (7.7%), bleeding (11.6%), and postoperative anemia (5.8%), with RR of 0.71 [0.58;0.87], 0.61 [0.52;0.71], and 0.64 [0.51;0.81]. The mean length of stay was 7.7 for open radical nephrectomy, 6.3 for laparoscopic radical nephrectomy, 7.5 for open partial nephrectomy, and 5 for laparoscopic partial nephrectomy.

Conclusions: The laparoscopic approach had fewer postoperative complications and a shorter length of stay than open surgery for partial and radical nephrectomy. The PMSI analysis provided an exhaustive description of surgical practice for kidney cancer and surgical complications in France.

Clinical trial number: Not applicable.

背景:腹腔镜手术的发病率低于开腹手术。最近还没有数据利用国家医疗保险数据库(PMSI-MCO)对法国人群的肾癌手术进行比较。目的:我们探讨并比较了腹腔镜和开腹肾癌手术的发病率:我们对2018年法国各中心肾癌患者的初始住院时间和术后三个月内的并发症参数进行了描述。我们比较了根治性和部分肾切除术中腹腔镜手术和开腹手术的相对风险(RR [95% CI]):在8162名患者中,3525人进行了根治性肾切除术,其中978人进行了开腹手术,2547人进行了腹腔镜手术;4637名患者进行了肾部分切除术,其中1778人进行了开腹手术,2859人进行了腹腔镜手术。在根治性手术中,最常见的并发症是泌尿系统感染(7.8%)、急性肾功能衰竭(8.9%)、败血症(8.4%)、出血(9.3%)和术后贫血(5.腹腔镜手术与开腹手术的RR分别为0.68 [0.54;0.86]、0.71 [0.57;0.88]、0.69 [0.55;0.86]、0.83 [0.66;1.03]、0.56 [0.43;0.73]。在肾部分切除术中,最常见的并发症是泌尿系统感染(7.7%)、出血(11.6%)和术后贫血(5.8%),RR 分别为 0.71 [0.58;0.87]、0.61 [0.52;0.71]和 0.64 [0.51;0.81]。开腹根治性肾切除术的平均住院时间为7.7天,腹腔镜根治性肾切除术为6.3天,开腹肾部分切除术为7.5天,腹腔镜肾部分切除术为5天:结论:与开腹手术相比,腹腔镜肾部分切除术和根治性肾切除术的术后并发症更少,住院时间更短。PMSI分析详尽描述了法国的肾癌手术实践和手术并发症:不适用。
{"title":"Open versus mini-invasive partial and radical nephrectomy complications: results from the French national health database.","authors":"Guillaume Pascal, Pascal Eschwège, Julia Salleron, Beverley Balkau, Jacques Hubert, Charles Mazeaud","doi":"10.1186/s12894-024-01620-7","DOIUrl":"10.1186/s12894-024-01620-7","url":null,"abstract":"<p><strong>Background: </strong>Laparoscopic surgery is associated with a lower morbidity than open surgery. No recent data compared kidney cancer surgery in the French population using the National Health Insurance database (PMSI-MCO).</p><p><strong>Aims: </strong>We explore and compare the surgical morbidity rates between laparoscopic and open laparotomy for kidney cancer.</p><p><strong>Methods: </strong>The initial length of stay and complications parameters during the three postoperative months were described for renal cancer in every French center in 2018. We compared Relative Risks (RR [95% CI]) between laparoscopic and open surgery for both radical and partial nephrectomy.</p><p><strong>Results: </strong>Among 8,162 patients, 3,525 had a radical nephrectomy, 978 open, 2,547 laparoscopic surgeries; 4,637 patients had partial nephrectomies, 1,778 open 2,859 laparoscopic surgeries. For radical surgery, the most common complications were urinary infections (7.8%), acute renal failure (8.9%), sepsis (8.4%), bleeding (9.3%), and postoperative anemia (5.9%); the RR for laparoscopic versus open surgery were respectively 0.68 [0.54;0.86], 0.71 [0.57;0.88], 0.69 [0.55;0.86], 0.83 [0.66;1.03], 0.56 [0.43;0.73]. For partial nephrectomies, the most common complications were urinary infections (7.7%), bleeding (11.6%), and postoperative anemia (5.8%), with RR of 0.71 [0.58;0.87], 0.61 [0.52;0.71], and 0.64 [0.51;0.81]. The mean length of stay was 7.7 for open radical nephrectomy, 6.3 for laparoscopic radical nephrectomy, 7.5 for open partial nephrectomy, and 5 for laparoscopic partial nephrectomy.</p><p><strong>Conclusions: </strong>The laparoscopic approach had fewer postoperative complications and a shorter length of stay than open surgery for partial and radical nephrectomy. The PMSI analysis provided an exhaustive description of surgical practice for kidney cancer and surgical complications in France.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"229"},"PeriodicalIF":1.7,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of laparoscopic, robotic and open nephroureterectomy with bladder cuff excision in patients with T3T4 upper urinary tract urothelial carcinoma: a multi-center retrospective study. T3T4上尿路尿路上皮癌患者腹腔镜、机器人和开放式肾切除术加膀胱袖带切除术的疗效:一项多中心回顾性研究。
IF 16.4 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-21 DOI: 10.1186/s12894-024-01622-5
Jen-Kai Fang, Hsin-Chih Yeh, Hsiang-Ying Lee, Han-Yu Weng, Ta-Yao Tai, Chao-Yuan Huang, Jian-Hua Hong, Chih-Chin Yu, Shu-Yu Wu, Shiu-Dong Chung, Chung-You Tsai, Thomas Y Hsueh, Allen W Chiu, Yuan-Hong Jiang, Yu Khun, Lee, I-Hsuan Alan Chen, Jen-Tai Lin, Yung-Tai Chen, Chang-Min Lin, Ian-Seng Cheong, Hsu-Che Huang, Shih-Hsiu Lo, Wei-Yu Lin, Jen-Shu Tseng, Chia-Chang Wu, Shian-Shiang Wang, Yi-Huei Chang, Chao-Hsiang Chang

Background: Nephroureterectomy with bladder cuff excision is the standard treatment for high-risk upper urinary tract urothelial carcinoma (UTUC). The role of minimally invasive surgery in treating locally advanced UTUC remains controversial. This study aimed to compare the outcomes of open, laparoscopic, and robotic surgeries for managing locally advanced UTUC.

Methods: We retrospectively reviewed 705 patients with locally advanced UTUC from multiple institutions throughout Taiwan. Perioperative outcomes and oncological outcomes, such as cancer-specific survival, overall survival, disease-free survival and bladder-free survival, were compared between the open, laparoscopic and robotic groups.

Results: The minimally invasive group had better overall and cancer-specific survival (CSS) rates. The 2-year CSS rates of the open, laparoscopic and robotic groups were 71%, 83%, and 77% respectively (p < 0.001). The robotic group had similar outcomes to the laparoscopic group. (p = 0.061, 0.825, 0.341 for OS, CSS, DFS respectively.) More lymph node dissections were performed and more lymph nodes were harvested in the robotic group (p = 0.009).

Conclusions: Our results demonstrated that minimally invasive surgery, including laparoscopic and robotic surgery, for locally advanced UTUC resulted in oncological outcomes that are non-inferior to those of open surgery.

背景:肾切除加膀胱袖带切除术是高危上尿路尿路上皮癌(UTUC)的标准治疗方法。微创手术在治疗局部晚期UTUC中的作用仍存在争议。本研究旨在比较开腹手术、腹腔镜手术和机器人手术治疗局部晚期UTUC的效果:我们回顾性研究了来自台湾多家医疗机构的705例局部晚期UTUC患者。比较了开腹组、腹腔镜组和机器人组的围手术期结果和肿瘤学结果,如癌症特异性生存率、总生存率、无病生存率和无膀胱生存率:结果:微创组的总生存率和癌症特异性生存率(CSS)更高。开腹组、腹腔镜组和机器人组的2年CSS率分别为71%、83%和77%(P 结论:我们的研究结果表明,微创手术是治疗膀胱癌的最佳方法:我们的研究结果表明,微创手术(包括腹腔镜手术和机器人手术)治疗局部晚期UTUC的肿瘤效果并不亚于开腹手术。
{"title":"Outcomes of laparoscopic, robotic and open nephroureterectomy with bladder cuff excision in patients with T3T4 upper urinary tract urothelial carcinoma: a multi-center retrospective study.","authors":"Jen-Kai Fang, Hsin-Chih Yeh, Hsiang-Ying Lee, Han-Yu Weng, Ta-Yao Tai, Chao-Yuan Huang, Jian-Hua Hong, Chih-Chin Yu, Shu-Yu Wu, Shiu-Dong Chung, Chung-You Tsai, Thomas Y Hsueh, Allen W Chiu, Yuan-Hong Jiang, Yu Khun, Lee, I-Hsuan Alan Chen, Jen-Tai Lin, Yung-Tai Chen, Chang-Min Lin, Ian-Seng Cheong, Hsu-Che Huang, Shih-Hsiu Lo, Wei-Yu Lin, Jen-Shu Tseng, Chia-Chang Wu, Shian-Shiang Wang, Yi-Huei Chang, Chao-Hsiang Chang","doi":"10.1186/s12894-024-01622-5","DOIUrl":"10.1186/s12894-024-01622-5","url":null,"abstract":"<p><strong>Background: </strong>Nephroureterectomy with bladder cuff excision is the standard treatment for high-risk upper urinary tract urothelial carcinoma (UTUC). The role of minimally invasive surgery in treating locally advanced UTUC remains controversial. This study aimed to compare the outcomes of open, laparoscopic, and robotic surgeries for managing locally advanced UTUC.</p><p><strong>Methods: </strong>We retrospectively reviewed 705 patients with locally advanced UTUC from multiple institutions throughout Taiwan. Perioperative outcomes and oncological outcomes, such as cancer-specific survival, overall survival, disease-free survival and bladder-free survival, were compared between the open, laparoscopic and robotic groups.</p><p><strong>Results: </strong>The minimally invasive group had better overall and cancer-specific survival (CSS) rates. The 2-year CSS rates of the open, laparoscopic and robotic groups were 71%, 83%, and 77% respectively (p < 0.001). The robotic group had similar outcomes to the laparoscopic group. (p = 0.061, 0.825, 0.341 for OS, CSS, DFS respectively.) More lymph node dissections were performed and more lymph nodes were harvested in the robotic group (p = 0.009).</p><p><strong>Conclusions: </strong>Our results demonstrated that minimally invasive surgery, including laparoscopic and robotic surgery, for locally advanced UTUC resulted in oncological outcomes that are non-inferior to those of open surgery.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"231"},"PeriodicalIF":16.4,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application value of surgical navigation system based on deep learning and mixed reality for guiding puncture in percutaneous nephrolithotomy: a retrospective study. 基于深度学习和混合现实技术的手术导航系统在经皮肾镜取石术中引导穿刺的应用价值:一项回顾性研究。
IF 1.7 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-21 DOI: 10.1186/s12894-024-01618-1
Xiangjun Meng, Daosheng Luo, Rujun Mo

Background: This study was conducted to investigate the clinical value of a navigation system based on deep learning and mixed reality for the treatment of kidney stones with percutaneous nephrolithotomy (PNL), and to improve its theoretical basis for the treatment of kidney stones.

Methods: The data of 136 patients with kidney stones from October 2021 to December 2023 were retrospectively analyzed. All patients underwent PNL, and were categorized into a control group (Group 1) and a surgical navigation group (Group 2) according to puncture positioning method. Preoperative computed tomography (CT) was performed in both groups. In group 1, procedures were performed under standard ultrasound guidance. PNL was performed with navigation system fused with ultrasound to guide percutaneous puncture in group 2. The baseline information and procedural characteristics of both groups were compared.

Results: PNL was successfully performed in both groups. No significant difference was found in the baseline date between the two groups. In group 2, real-time ultrasound images could be accurately matched with CT images with the aid of navigation system. The success rate of single puncture, puncture time, and decrease in hemoglobin were significantly improved in group 2 compared to group 1. (p < 0.05).

Conclusions: The application of navigation system based on deep learning and mixed reality in PNL for kidney stones allows for real-time intraoperative navigation, with acceptable accuracy and safety. Most importantly, this technique is easily mastered, particularly by novice surgeons in the field of PNL.

研究背景本研究旨在探讨基于深度学习和混合现实的导航系统在经皮肾镜(PNL)治疗肾结石中的临床价值,完善其治疗肾结石的理论基础:回顾性分析2021年10月至2023年12月136例肾结石患者的数据。所有患者均接受了 PNL,并根据穿刺定位方法分为对照组(第 1 组)和手术导航组(第 2 组)。两组患者均进行了术前计算机断层扫描(CT)。第一组在标准超声引导下进行手术。比较了两组的基线信息和手术特点:结果:两组均成功实施了 PNL。结果:两组均成功实施了 PNL,两组的基线日期无明显差异。在第二组中,借助导航系统,实时超声图像可与 CT 图像准确匹配。与第一组相比,第二组的单次穿刺成功率、穿刺时间和血红蛋白下降率均有明显改善:基于深度学习和混合现实技术的导航系统在肾结石 PNL 中的应用可实现术中实时导航,其准确性和安全性均可接受。最重要的是,这项技术很容易掌握,特别是对于 PNL 领域的外科医生新手而言。
{"title":"Application value of surgical navigation system based on deep learning and mixed reality for guiding puncture in percutaneous nephrolithotomy: a retrospective study.","authors":"Xiangjun Meng, Daosheng Luo, Rujun Mo","doi":"10.1186/s12894-024-01618-1","DOIUrl":"10.1186/s12894-024-01618-1","url":null,"abstract":"<p><strong>Background: </strong>This study was conducted to investigate the clinical value of a navigation system based on deep learning and mixed reality for the treatment of kidney stones with percutaneous nephrolithotomy (PNL), and to improve its theoretical basis for the treatment of kidney stones.</p><p><strong>Methods: </strong>The data of 136 patients with kidney stones from October 2021 to December 2023 were retrospectively analyzed. All patients underwent PNL, and were categorized into a control group (Group 1) and a surgical navigation group (Group 2) according to puncture positioning method. Preoperative computed tomography (CT) was performed in both groups. In group 1, procedures were performed under standard ultrasound guidance. PNL was performed with navigation system fused with ultrasound to guide percutaneous puncture in group 2. The baseline information and procedural characteristics of both groups were compared.</p><p><strong>Results: </strong>PNL was successfully performed in both groups. No significant difference was found in the baseline date between the two groups. In group 2, real-time ultrasound images could be accurately matched with CT images with the aid of navigation system. The success rate of single puncture, puncture time, and decrease in hemoglobin were significantly improved in group 2 compared to group 1. (p < 0.05).</p><p><strong>Conclusions: </strong>The application of navigation system based on deep learning and mixed reality in PNL for kidney stones allows for real-time intraoperative navigation, with acceptable accuracy and safety. Most importantly, this technique is easily mastered, particularly by novice surgeons in the field of PNL.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"230"},"PeriodicalIF":1.7,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unilateral polyorchidism with severe male infertility: a case report. 单侧多睾症伴严重男性不育:病例报告。
IF 1.7 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-18 DOI: 10.1186/s12894-024-01626-1
Fang Yang, Jingyi Zhang, Yao Xiao, Shiyun Pu, Meijing Wang, Shengxi Xiong, Xinyi Tang, Xujun Yu, Degui Chang

Polyorchidism is an uncommon congenital condition often discovered incidentally, which may significantly impact male fertility. We present a case of a 34-year-old man with unilateral polyorchidism and associated severe asthenozoospermia and teratozoospermia. Despite normal hormonal levels and no detected genetic anomalies, the patient's sperm showed mitochondrial damage, and his fertility remained compromised after conservative management and assisted reproductive attempts. This case underscores the intricate relationship between polyorchidism and male infertility, highlighting the need for personalized management strategies and further research into its etiology and impact.

多睾丸症是一种不常见的先天性疾病,往往是偶然发现的,可能会严重影响男性的生育能力。我们介绍了一例 34 岁男性单侧多睾丸症病例,患者伴有严重的无精子症和畸形精子症。尽管患者体内激素水平正常,也未发现遗传异常,但其精子却出现线粒体损伤,经过保守治疗和辅助生殖尝试后,其生育能力仍然受到影响。本病例强调了多睾症与男性不育之间错综复杂的关系,突出了个性化管理策略和进一步研究其病因和影响的必要性。
{"title":"Unilateral polyorchidism with severe male infertility: a case report.","authors":"Fang Yang, Jingyi Zhang, Yao Xiao, Shiyun Pu, Meijing Wang, Shengxi Xiong, Xinyi Tang, Xujun Yu, Degui Chang","doi":"10.1186/s12894-024-01626-1","DOIUrl":"10.1186/s12894-024-01626-1","url":null,"abstract":"<p><p>Polyorchidism is an uncommon congenital condition often discovered incidentally, which may significantly impact male fertility. We present a case of a 34-year-old man with unilateral polyorchidism and associated severe asthenozoospermia and teratozoospermia. Despite normal hormonal levels and no detected genetic anomalies, the patient's sperm showed mitochondrial damage, and his fertility remained compromised after conservative management and assisted reproductive attempts. This case underscores the intricate relationship between polyorchidism and male infertility, highlighting the need for personalized management strategies and further research into its etiology and impact.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"228"},"PeriodicalIF":1.7,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical application and efficacy analysis of robot-assisted laparoscopic tumor enucleation combined with tumor aspiration in the treatment of renal hilar angiomyolipoma. 机器人辅助腹腔镜肿瘤去核联合肿瘤抽吸术治疗肾门血管瘤的临床应用及疗效分析
IF 1.7 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-10-17 DOI: 10.1186/s12894-024-01623-4
Zhenyu Xu, Haixiang Qin, Mei Yu, Qing Zhang, Xiaogong Li, Hongqian Guo, Guangxiang Liu

Background: For renal hilar angiomyolipoma, general surgical resection is often quite challenging. The aim of this study is to evaluate the safety and efficacy of an innovative robot-assisted laparoscopic strategy that combines tumor enucleation with tumor aspiration in the treatment of renal hilar angiomyolipoma.

Methods: The clinical data of 38 patients with renal hilar angiomyolipoma who went through robotic tumor enucleation combined with tumor aspiration in the Department of Urology, the Affiliated Hospital of Nanjing University Medical School, from December 2019 to December 2022 were retrospectively analyzed. The basic characteristics, the perioperative variables, intraoperative procedures, and postoperative complications were all recorded. Patients were followed up to evaluate the angiomyolipoma recurrence and the renal function by urologic CT or ultrasound and renal function tests.

Results: All surgeries were successfully completed without conversion to radical nephrectomy or open surgery. One patient developed urinary extravasation 10 days after surgery, and was readmitted to the hospital for transurethral ureteral stenting considering the injury of the renal collecting system. The median operative time was 181.5 (123.8-206.3) min, the warm ischemia time was 20.0 (17.3-24.0) min, the blood loss was 125 (100.0-262.5) ml, and no patients received blood transfusion during and after surgery. The median hospitalization time was 7.0 (6.0-9.0) days, and the duration of indwelling drainage tube was 2.0 (2.0-3.0) days. The serum creatinine (Scr) on the first day, 3 months, and 6 months after surgery were 55.5 (50.8-62.8) µmol/L, 55.5 (48.0-62.0) µmol/L and 54.0 (51.8-63.5) µmol/L, respectively, and there was no significant difference compared with the preoperative level 56.0 (47.8-60.3) µmol/L. All patients were followed up after surgery, and the urinary CT scan or renal color doppler ultrasound, and renal function were reexamined. The median follow-up time of all patients was 19.0 (14.75-33.0) months, and no local recurrence of angiomyolipoma was seen in all patients.

Conclusions: The surgical strategy of robot-assisted laparoscopic tumor enucleation combined with tumor aspiration is safe and effective in the treatment of renal hilar angiomyolipoma.

背景:对于肾门血管瘤而言,一般的手术切除往往具有相当大的挑战性。本研究旨在评估一种创新的机器人辅助腹腔镜策略的安全性和有效性:方法:回顾性分析2019年12月至2022年12月南京大学医学院附属医院泌尿外科采用机器人辅助腹腔镜下肿瘤去核联合肿瘤抽吸术治疗的38例肾门血管瘤患者的临床资料。记录了患者的基本特征、围手术期变量、术中操作和术后并发症。对患者进行随访,通过泌尿系统CT或B超和肾功能检查评估血管肌脂肪瘤复发情况和肾功能:结果:所有手术均顺利完成,未转为根治性肾切除术或开放手术。一名患者在术后 10 天出现尿液外渗,考虑到肾集合系统损伤,再次入院进行经尿道输尿管支架植入术。中位手术时间为 181.5(123.8-206.3)分钟,温热缺血时间为 20.0(17.3-24.0)分钟,失血量为 125(100.0-262.5)毫升,术中和术后没有患者输血。中位住院时间为 7.0(6.0-9.0)天,留置引流管时间为 2.0(2.0-3.0)天。术后第一天、3 个月和 6 个月的血清肌酐(Scr)分别为 55.5(50.8-62.8)µmol/L、55.5(48.0-62.0)µmol/L 和 54.0(51.8-63.5)µmol/L,与术前的 56.0(47.8-60.3)µmol/L 相比无显著差异。术后对所有患者进行了随访,并重新检查了尿液 CT 扫描或肾脏彩色多普勒超声以及肾功能。所有患者的中位随访时间为19.0(14.75-33.0)个月,所有患者均未发现血管瘤局部复发:结论:机器人辅助腹腔镜肿瘤去核联合肿瘤抽吸术是治疗肾门血管瘤的安全有效的手术策略。
{"title":"Clinical application and efficacy analysis of robot-assisted laparoscopic tumor enucleation combined with tumor aspiration in the treatment of renal hilar angiomyolipoma.","authors":"Zhenyu Xu, Haixiang Qin, Mei Yu, Qing Zhang, Xiaogong Li, Hongqian Guo, Guangxiang Liu","doi":"10.1186/s12894-024-01623-4","DOIUrl":"https://doi.org/10.1186/s12894-024-01623-4","url":null,"abstract":"<p><strong>Background: </strong>For renal hilar angiomyolipoma, general surgical resection is often quite challenging. The aim of this study is to evaluate the safety and efficacy of an innovative robot-assisted laparoscopic strategy that combines tumor enucleation with tumor aspiration in the treatment of renal hilar angiomyolipoma.</p><p><strong>Methods: </strong>The clinical data of 38 patients with renal hilar angiomyolipoma who went through robotic tumor enucleation combined with tumor aspiration in the Department of Urology, the Affiliated Hospital of Nanjing University Medical School, from December 2019 to December 2022 were retrospectively analyzed. The basic characteristics, the perioperative variables, intraoperative procedures, and postoperative complications were all recorded. Patients were followed up to evaluate the angiomyolipoma recurrence and the renal function by urologic CT or ultrasound and renal function tests.</p><p><strong>Results: </strong>All surgeries were successfully completed without conversion to radical nephrectomy or open surgery. One patient developed urinary extravasation 10 days after surgery, and was readmitted to the hospital for transurethral ureteral stenting considering the injury of the renal collecting system. The median operative time was 181.5 (123.8-206.3) min, the warm ischemia time was 20.0 (17.3-24.0) min, the blood loss was 125 (100.0-262.5) ml, and no patients received blood transfusion during and after surgery. The median hospitalization time was 7.0 (6.0-9.0) days, and the duration of indwelling drainage tube was 2.0 (2.0-3.0) days. The serum creatinine (Scr) on the first day, 3 months, and 6 months after surgery were 55.5 (50.8-62.8) µmol/L, 55.5 (48.0-62.0) µmol/L and 54.0 (51.8-63.5) µmol/L, respectively, and there was no significant difference compared with the preoperative level 56.0 (47.8-60.3) µmol/L. All patients were followed up after surgery, and the urinary CT scan or renal color doppler ultrasound, and renal function were reexamined. The median follow-up time of all patients was 19.0 (14.75-33.0) months, and no local recurrence of angiomyolipoma was seen in all patients.</p><p><strong>Conclusions: </strong>The surgical strategy of robot-assisted laparoscopic tumor enucleation combined with tumor aspiration is safe and effective in the treatment of renal hilar angiomyolipoma.</p>","PeriodicalId":9285,"journal":{"name":"BMC Urology","volume":"24 1","pages":"227"},"PeriodicalIF":1.7,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1